Bergamo, Italy

Joseê Golay

This inventor holds 1 USPTO granted patent. Top assignee: Italfarmaco Spa. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseê Golay. Retrieved from https://idiyas.com/inventor/joseê-golay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Joseê Golay

Introduction

Joseê Golay is a notable inventor based in Bergamo, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of specific myeloproliferative syndromes. His work is characterized by a commitment to improving patient outcomes through innovative methods.

Latest Patents

Joseê Golay holds a patent for a method aimed at treating Philadelphia-negative myeloproliferative syndromes. This method involves administering diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates, in combination with N-hydroxyurea, to patients in need of such treatment. This patent highlights his dedication to advancing therapeutic options for patients suffering from these conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Joseê Golay has been associated with Italfarmaco Spa, a company known for its focus on pharmaceutical innovations. His role at the company has allowed him to contribute to the development of new treatments and therapies that address unmet medical needs.

Collaborations

Joseê has worked alongside esteemed colleagues such as Paolo Mascagni and Carmine D'urzo. Their collaborative efforts have further enhanced the research and development initiatives within their field.

Conclusion

Joseê Golay's innovative work in the treatment of Philadelphia-negative myeloproliferative syndromes exemplifies the impact that dedicated inventors can have on healthcare. His contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…